rx 821002 has been researched along with n-formylmethionine leucyl-phenylalanine in 1 studies
Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (n-formylmethionine leucyl-phenylalanine) | Trials (n-formylmethionine leucyl-phenylalanine) | Recent Studies (post-2010) (n-formylmethionine leucyl-phenylalanine) |
---|---|---|---|---|---|
317 | 0 | 45 | 6,716 | 53 | 356 |
Protein | Taxonomy | rx 821002 (IC50) | n-formylmethionine leucyl-phenylalanine (IC50) |
---|---|---|---|
fMet-Leu-Phe receptor | Homo sapiens (human) | 0.02 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Musgrave, IF; Seifert, R | 1 |
1 other study(ies) available for rx 821002 and n-formylmethionine leucyl-phenylalanine
Article | Year |
---|---|
Human neutrophils and HL-60 cells do not possess alpha 2-adrenoceptors.
Topics: Adrenergic alpha-Agonists; Azepines; Brimonidine Tartrate; Dioxanes; GTP Phosphohydrolases; Humans; Idazoxan; Isoproterenol; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Quinoxalines; Receptors, Adrenergic, alpha; Superoxides; Tritium; Tumor Cells, Cultured | 1994 |